Key Insights

Highlights

Success Rate

86% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

5.3%

1 terminated out of 19 trials

Success Rate

85.7%

-0.8% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

17%

1 of 6 completed with results

Key Signals

1 with results86% success

Data Visualizations

Phase Distribution

10Total
Not Applicable (5)
Early P 1 (2)
P 2 (3)

Trial Status

Completed6
Unknown4
Active Not Recruiting4
Recruiting4
Terminated1

Trial Success Rate

85.7%

Benchmark: 86.5%

Based on 6 completed trials

Clinical Trials (19)

Showing 19 of 19 trials
NCT03546972Not ApplicableActive Not Recruiting

Diabetes Prevention Program With or Without Hunger Training in Helping to Lower Breast Cancer Risk in Obese Participants

NCT02790853Early Phase 1Active Not Recruiting

Multimodal Imaging for Surveillance in Patients With Oral Potentially Malignant Disorders

NCT00542373Not ApplicableActive Not Recruiting

Widefield Fluorescence and Reflectance Imaging Systems and Oral Tissue Samples in Monitoring Participants at Risk for Developing Oral Cancer

NCT06561087Phase 2RecruitingPrimary

Phase II Randomized, Placebo- Controlled Study of Intralesional Nivolumab for High-risk Oral Premalignant Lesions

NCT07056374Recruiting

Adaptive Anastomosis for Anterior Resection in Sigmoid and Proximal Rectal Cancer or Premalignant Lesions

NCT05762991Recruiting

Application of Artificial Intelligence on the Diagnosis of Helicobacter Pylori Infection and Premalignant Gastric Lesion

NCT06728631Phase 2Active Not Recruiting

Candonilimab and ATRA Acid for Prevention of Oral Cancer Recurrence in Patients With OPL

NCT05451303Recruiting

Detection of Oral and Throat Cancers Using OralViome Cancer Testing System

NCT06060288UnknownPrimary

Diagnostic Accuracy of Mobile Phone Imaging Compared to Conventional Clinical Examination for Oral Cancer Screening

NCT03268993Not ApplicableCompleted

Effects of Avmacol® in the Oral Mucosa of Patients Following Curative Treatment for Tobacco-related Head and Neck Cancer

NCT05766150Unknown

Oral Microbioma and Oral Malignant Disease

NCT04926688CompletedPrimary

High-risk Breast Lesions: A Multicenter Retrospective Study

NCT03182959Early Phase 1Completed

Broccoli Sprout Extract in Preventing Recurrence in Patients With Tobacco-Related Head and Neck Squamous Cell Cancer

NCT03208790Phase 2CompletedPrimary

Clinical and Immunohisochemical Evaluation of Chemopreventive Effect of Thymoquinone on Oral Potentially Malignant Lesions.

NCT04732741Unknown

Diagnostic Accuracy of Salivary Gamma-synuclein in Oral Malignant and Premalignant Lesions

NCT03276819Not ApplicableTerminatedPrimary

A Clinical and Biological Umbrella Protocol for Smoker or Non-smoker Patients With OPML or HNSCC

NCT04172272Not ApplicableUnknown

The Influence of TAP Block in the Control of Postoperative Pain After Laparotomy for Gynecological Procedures

NCT03830710CompletedPrimary

8-Hydroxy-2-Deoxyguanosine ,Total Antioxidant Capacity in Oral Premalignant and Malignant Lesions

NCT03031899Completed

Comparison or Rose Bengal and Toluidine Blue Staining for Lesion Detection Efficacy

Showing all 19 trials

Research Network

Activity Timeline